How much funding has Stamm raised?

Stamm has raised $20.0M in total funding, most recently a Series A round.

Who are Stamm's investors?

Stamm's investors include Varana Capital, SOSV.

Where is Stamm headquartered?

Stamm is headquartered in San Francisco, California, United States.

What industry is Stamm in?

Stamm operates in Biotech, Healthcare.

Stamm

San Francisco, United States · Founded 2016 · $20.0M raised

Biotech

Healthcare

Headquarters: San Francisco, California
Employees: 201–500
Founded: 2016
Business Model: B2B

Total Funding: $20.0M
Last Round: $17.0M Series AFeb 2022
Rounds: 2

About

Stämm is a San Francisco-based biomanufacturing company that develops advanced bioprocessing platforms inspired by laminar flow in nature. The company's High-throughput Bioprocessor miniaturizes an entire biotech facility into a compact, plug-and-play desktop unit, enabling biologics production, cell line development, and cell therapy manufacturing at a fraction of traditional scale. Stämm also offers bioengineering services for clinical and commercial cell line development, and a Bio AI platform that builds cell-predictive pipelines using multi-omics data and generative AI models. Founded in 2016 by Yuyo Llamazares Vegh and Federico D'Alvia Vegh, the company operates across the US, Argentina, and Switzerland.

Summary

Stamm is a Biotech company based in San Francisco, United States, founded in 2016. It has raised $20.0M in total across 2 rounds, most recently a $17.0M Series A round in Feb 2022. Investors include Varana Capital and SOSV.

LinkedIn X (Twitter)